Weekly Market Roundup

  • Bitmine Raises $273.8M for ETH as Sezzle Jumps on Fragile Iran Deal

    Bitmine Raises $273.8M for ETH as Sezzle Jumps on Fragile Iran Deal

    Sezzle jumped 10.1% on June 15 because a deal in Switzerland promised to reopen the Strait of Hormuz. By June 18, Iran had closed it again. Bitmine Raises $273.8 Million in Preferred Stock to Buy More Ethereum While Diluting Shareholders 213-Fold Bitmine Immersion Technologies (NYSE: BMNR) announced on June 15 that its total crypto, cash,…

    read more

  • Eos Energy Up 12% on Battery Line 2 as Brenmiller Eyes Italy Market

    Eos Energy Up 12% on Battery Line 2 as Brenmiller Eyes Italy Market

    Eos Energy’s stock is down 52% over six months. On June 16, it jumped 12% in a single morning. Eos Energy Launches Battery Line 2 and Stock Jumps 12% Despite Being Down 52% Over Six Months Eos Energy Enterprises (Nasdaq: EOSE) announced on June 16 that it had started commercial production on Battery Line 2…

    read more

  • Intel Surges 10% After Trump Confirms Apple Chip Deal as Accenture Drops 13% on Guidance Cut

    Intel Surges 10% After Trump Confirms Apple Chip Deal as Accenture Drops 13% on Guidance Cut

    Intel’s 18A node packs 238 million transistors per square millimeter. TSMC’s competing N2 node packs 313 million. On June 18, Apple agreed to use Intel anyway, just not for the chips that matter most yet. Intel Surges After Trump Confirms Apple Will Use Intel Foundry for US-Made Chips President Trump posted on Truth Social early…

    read more

  • Pancreatic Cancer Trial Ahead of Schedule, Gastric Cancer Fast Track Win

    Pancreatic Cancer Trial Ahead of Schedule, Gastric Cancer Fast Track Win

    A drug called givastomig produced a 77% response rate in gastric cancer. The stock trades 71% below its 52-week high. Sometimes the data and the price tell two different stories. AIM ImmunoTech Doses Final Patient in Phase 2 Pancreatic Cancer Trial Ahead of Schedule AIM ImmunoTech (NYSE American: AIM) had a busy stretch in the…

    read more

  • Banyan Gold 62.66 g/t Yukon Find and Formation Metals N2 Extension

    Banyan Gold 62.66 g/t Yukon Find and Formation Metals N2 Extension

    Gold averaged $3,300 an ounce this month. At a 0.30 g/t cutoff, that turns marginal rock into ore. Banyan Gold just drilled 62.66 grams per tonne. That is not marginal rock. Banyan Gold Intersects 62.66 g/t Gold in a New High-Grade Zone at the Powerline Deposit, Yukon Banyan Gold Corp. (TSXV: BYN / OTCQB: BYAGF)…

    read more

  • Hut 8 Closes $4.25B AI Bond and Coinbase Launches Crypto Agents

    Hut 8 Closes $4.25B AI Bond and Coinbase Launches Crypto Agents

    Bitcoin mining companies used to fund themselves by selling the coins they dug up. Hut 8 just raised $4.25 billion in bonds. These are not the same business model. Hut 8 Closes $4.25 Billion Texas AI Data Center Bond and Appoints Stanley O’Neal as Chairman On June 10, Hut 8 Corp. (Nasdaq: HUT) closed a…

    read more

  • 374Water PFAS Capacity Upgrade and PureCycle Packaging Milestone

    374Water PFAS Capacity Upgrade and PureCycle Packaging Milestone

    PFAS has been detected in the blood of 97% of Americans. It does not biodegrade. Most technologies capture it, concentrate it, or move it somewhere else. 374Water’s technology destroys it permanently. On June 9, the company upgraded the facility that does that. 374Water Expands Iron Bridge Facility Targeting $3 Million to $5 Million in Annual…

    read more

  • Siri Gets Rebuilt, SpaceX Goes Public: The Week That Changed AI Markets

    Siri Gets Rebuilt, SpaceX Goes Public: The Week That Changed AI Markets

    Siri has been the butt of the joke for five years. On June 8, Apple spent $1 billion to fix that. Apple WWDC 2026 Reveals Siri AI Powered by Custom 1.2 Trillion Parameter Gemini Model Apple’s Worldwide Developers Conference opened June 8 at Apple Park. The keynote landed with a specific number: 1.2 trillion parameters.…

    read more

  • Pancreatic Cancer Phase 3 Starts, Ovarian Cancer Phase 1 Wins

    Pancreatic Cancer Phase 3 Starts, Ovarian Cancer Phase 1 Wins

    51,000 Americans will be diagnosed with pancreatic cancer this year. Roughly 45,000 will die from it. The five-year survival rate has not meaningfully changed since 2000. On June 11, a company called Immuneering dosed its first Phase 3 patient. Immuneering Corporation Doses First Patient in Phase 3 MAPKeeper 301 Pancreatic Cancer Trial Immuneering Corporation (Nasdaq:…

    read more

  • Group Eleven 23% Copper in Ireland, Gold Terra and Tier One Silver Results

    Group Eleven 23% Copper in Ireland, Gold Terra and Tier One Silver Results

    Gold held near $3,300 this week. Silver was volatile between $32 and $34. The drill rigs did not care. Four junior mining companies released results across Ireland, Canada, and Peru — copper, gold, silver, and the kind of antimony grades that put a European discovery on the critical minerals map. Group Eleven Resources Drills 23.60%…

    read more